<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recommendations for the management of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> include rigorous control of blood <z:chebi fb="105" ids="17234">glucose</z:chebi> levels and other risk factors, such as <z:hpo ids='HP_0000822'>hypertension</z:hpo> and <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidaemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In clinical practice, many patients do not reach goals for glycaemic control </plain></SENT>
<SENT sid="2" pm="."><plain>Causes of failure to control blood <z:chebi fb="105" ids="17234">glucose</z:chebi> include progression of underlying pancreatic <z:hpo ids='HP_0006279'>beta-cell dysfunction</z:hpo>, incomplete adherence to treatment (often because of adverse effects of <z:mp ids='MP_0005456'>weight gain</z:mp> and <z:e sem="disease" ids="C0020615" disease_type="Disease or Syndrome" abbrv="">hypoglycaemia</z:e>) and reluctance of clinicians to intensify therapy </plain></SENT>
<SENT sid="3" pm="."><plain>There is increasing focus on strategies that offer potential to improve glycaemic control </plain></SENT>
<SENT sid="4" pm="."><plain>Structured patient education has been shown to improve glycaemic control and other <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> in people with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Payment of general practitioners by results has been shown to improve glycaemic control </plain></SENT>
<SENT sid="6" pm="."><plain>New classes of <z:chebi fb="105" ids="17234">glucose</z:chebi>-lowering agents have expanded the treatment options available to clinicians and patients and include the dipeptidyl peptidase 4 (DPP-4) inhibitors and glucagon-like <z:chebi fb="7" ids="16670">peptide</z:chebi>-1 (GLP-1) receptor <z:chebi fb="4" ids="48705">agonists</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>These new classes of therapy and other strategies outlined above could help clinicians to individualize treatment and help a greater proportion of patients to achieve long-term control of blood <z:chebi fb="105" ids="17234">glucose</z:chebi> </plain></SENT>
</text></document>